Compare HAE & PTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HAE | PTY |
|---|---|---|
| Founded | 1971 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.5B |
| IPO Year | 1996 | 2002 |
| Metric | HAE | PTY |
|---|---|---|
| Price | $60.24 | $12.10 |
| Analyst Decision | Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $84.13 | N/A |
| AVG Volume (30 Days) | 531.4K | ★ 1.4M |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 44.54 | N/A |
| EPS | ★ 2.46 | N/A |
| Revenue | ★ $910,373,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.23 | N/A |
| P/E Ratio | $25.16 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $47.32 | $11.58 |
| 52 Week High | $87.32 | $14.69 |
| Indicator | HAE | PTY |
|---|---|---|
| Relative Strength Index (RSI) | 53.79 | 45.56 |
| Support Level | $48.47 | N/A |
| Resistance Level | $66.86 | $13.21 |
| Average True Range (ATR) | 1.87 | 0.15 |
| MACD | 0.70 | 0.04 |
| Stochastic Oscillator | 73.37 | 68.59 |
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.
PIMCO Corporate & Income Opportunity Fds operates as a closed-end management investment company. It seeks to maximize total return through a combination of current income and capital appreciation. The fund invests a majority of the total assets in a combination of corporate debt obligations of varying maturities, other corporate income-producing securities, and income-producing securities of non-corporate issuers, such as U.S. Government securities, municipal securities, and mortgage-backed and other asset-backed securities issued on a public or private basis.